ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,465.95
0.41%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
0.00%
Brent Oil
82.275
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFMW)

  7. Sunshine Biopharma Inc (SBFMW) ニュース

SBFMW

Sunshine Biopharma (SBFMW)

Sunshine Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SBFMW
日付受信時刻ニュースソース見出しコード企業名
2024/06/1205 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/06/0805 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/2305 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/2104 : 34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMWSunshine Biopharma Inc
2024/05/1523 : 40Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/0905 : 21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/0701 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2023/12/0422 : 30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMWSunshine Biopharma Inc
2023/08/1121 : 30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMWSunshine Biopharma Inc
2023/05/1622 : 58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2023/05/1221 : 00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2023/05/1122 : 00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMWSunshine Biopharma Inc
2023/04/0521 : 00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMWSunshine Biopharma Inc
2023/02/2821 : 30GlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMWSunshine Biopharma Inc
2023/02/1021 : 35GlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMWSunshine Biopharma Inc
2023/01/1921 : 30GlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMWSunshine Biopharma Inc
2022/12/2022 : 00GlobeNewswire Inc.Sunshine Biopharma’s Annual Letter to ShareholdersNASDAQ:SBFMWSunshine Biopharma Inc
2022/11/1622 : 00GlobeNewswire Inc.Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA ProjectNASDAQ:SBFMWSunshine Biopharma Inc
2022/10/2021 : 00GlobeNewswire Inc.Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueNASDAQ:SBFMWSunshine Biopharma Inc
2022/08/0421 : 00GlobeNewswire Inc.Sunshine Biopharma Files Its Second Quarter Report With the SECNASDAQ:SBFMWSunshine Biopharma Inc
2022/07/2821 : 10GlobeNewswire Inc.Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/2905 : 50GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/2613 : 41GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/2521 : 00GlobeNewswire Inc.Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/0521 : 00GlobeNewswire Inc.Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
2022/03/1507 : 12GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/03/1023 : 17GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/02/2600 : 20InvestorsHub NewsWireSUNSHINE BIOPHARMA EXPANDS ANTI-CORONAVIRUS DRUG DEVELOPMENT PROGRAM BY SIGNING A COLLABORATION AGREEMENT WITH THE UNIVERSITY OF ARIZONANASDAQ:SBFMWSunshine Biopharma Inc
2022/02/2522 : 00GlobeNewswire Inc.Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
2022/02/1800 : 07GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:SBFMWSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFMW

最近閲覧した銘柄

NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
USI
USTECH100
US Tech 100
FX
USDGBP
US Dollar vs Sterling
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有